GET DAILY SIGNALSBath & Body Works (BBWI): What to Expect from Q1 Fiscal 2026 Earnings
Key Takeaways
- Analysts expect Q1 fiscal 2026 adjusted EPS of $0.29, aligning with company guidance of $0.24-$0.30.
- Consensus revenue forecast is $1.36 billion, down about 4.5% from $1.424 billion in Q1 last year, matching guided 4%-6% decline.
- Key metrics to watch include gross profit rate around 42.5% amid tariff headwinds (about 150 basis points), adjusted SG&A rate near 32.3%, and buy-and-other dollars.
- Fiscal 2026 full-year guidance signals net sales down 2.5%-4.5% and adjusted EPS $2.40-$2.65, reflecting cautious consumer spending.
- BBWI has beaten EPS estimates in recent quarters, including Q4 2025's $2.05 vs. $1.77 expected.
- Investor focus on progress in "Consumer First Formula" strategy amid softer retail demand.
Earnings Context and Why It Matters
As we approach the Bath & Body Works (BBWI) Q1 fiscal 2026 earnings report on May 27, 2026, I'm paying close attention to how this specialty retailer of personal care and home fragrance products is navigating broader retail headwinds. Budget-conscious consumers are pulling back on non-essentials like fragrances and candles, driven by rising living costs and a softening labor market. After delivering an adjusted EPS beat of $2.05 against $1.77 expected in Q4 2025—despite flat full-year sales—this report could signal whether stabilization is underway. In my view, it will provide key insights into the early execution of the "Consumer First Formula," which prioritizes innovation in core categories, even as guided sales declines persist. For investors, the focus will be on margin resilience, tariff impacts, and demand trends in the competitive beauty sector.
Earnings Expectations
Wall Street's consensus points to Q1 fiscal 2026 revenue—ending around early May 2026—of $1.36 billion, a roughly 4.5% year-over-year decline from $1.424 billion in Q1 fiscal 2025. This aligns neatly with the company's guidance for a 4%-6% drop. Adjusted EPS is expected at $0.29 according to 15 analysts, fitting within BBWI's outlook of $0.24-$0.30 (or reported EPS of $0.84-$0.90), compared to $0.49 in Q1 2025.
One thing that stands out is the scrutiny on gross margins, projected around 42.5% and pressured by about 150 basis points from tariffs, alongside an adjusted SG&A rate near 32.3% and flat buy-and-other dollars. Looking ahead, full-year fiscal 2026 guidance calls for net sales down 2.5%-4.5% to about $7.0 billion and adjusted EPS of $2.40-$2.65. This assumes no share repurchases and around $600 million in free cash flow. Historically, BBWI has a strong track record of EPS beats, as seen in Q4 2025, though stock reactions can vary—recent results showed initial gains tempered by softer guidance.
Market Reaction and Investor Sentiment
Sentiment around BBWI remains cautious heading into these earnings, with shares under pressure from broader retail challenges and the conservative fiscal 2026 guidance issued after Q4. Analysts highlight risks like heightened promotional intensity and value-oriented consumer behavior, but the company's 100% EPS beat rate in recent quarters offers some balance. Tariff headwinds—around 150 basis points to Q1 gross margins—and softer body care demand are concerns, though home fragrance strengths provide an offset. After Q4, the stock rose initially on the beat but retraced on guidance, underscoring its sensitivity to the forward outlook. From what I see, pre-earnings positioning will likely depend on updates to the Consumer First strategy.
Why I Use Tickeron’s AI Screener
In my own research process, I’ve found Tickeron’s AI Screener particularly useful for digging into stocks like BBWI. This AI-powered tool lets me filter thousands of stocks and ETFs based on technical patterns, fundamentals, trends, volatility, and AI-driven signals—using customizable criteria like industry, market cap, indicators, price patterns, and performance metrics. It streamlines identifying trade ideas, breakout candidates, and opportunities in sectors like retail far more efficiently than manual methods. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry, and it’s helped sharpen my perspective on relative positioning.
Forward Outlook and Key Factors to Monitor
Post-Q1, I'll be watching how closely BBWI adheres to its fiscal 2026 guidance: net sales down 2.5%-4.5% and adjusted EPS of $2.40-$2.65. This factors in moves like redeeming $284 million in January 2027 bonds to save on interest and generating about $600 million in free cash flow, with no repurchases assumed.
Progress on the "Consumer First Formula" is core here, with plans to ramp product innovation in the second half of 2026 through upgraded packaging, higher fragrance loads, and efficacy claims in body care and home fragrance. Management expects about 1% square footage growth, mid-to-high single-digit international sales increases, and lifts from expanded distribution such as Amazon—around $50 million or a 0.5-point sales boost.
Macro factors include ongoing consumer caution on non-essentials due to cost-of-living pressures, flat promotional intensity, and neutral year-over-year tariff impacts. Margin details—gross rate around 42.4% under 130 basis points of pressure, adjusted SG&A at about 29.2%—along with non-operating expenses of roughly $230 million and a 26.5% tax rate, will indicate operational strength. This is important because execution on Fuel for Growth savings (about $175 million in 2026), CapEx around $270 million, and category shifts—like scaling back laundry to prioritize fragrances—will be telling amid demand resets. I’m watching this closely for signs of resilience.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
BBWI's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for BBWI turned positive on October 05, 2026. Looking at past instances where BBWI's MACD turned positive, the stock continued to rise in 36 of 49 cases over the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on BBWI as a result. In 60 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
BBWI moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BBWI crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +4.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where BBWI advanced for three days, in 193 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Aroon Indicator entered an Uptrend today. In 96 of 145 cases where BBWI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 13 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBWI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
BBWI broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. BBWI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-4.428) is normal, around the industry mean (2.273). P/E Ratio (6.087) is within average values for comparable stocks, (17.299). Projected Growth (PEG Ratio) (0.658) is also within normal values, averaging (1.159). Dividend Yield (0.034) settles around the average of (0.095) among similar stocks. P/S Ratio (0.472) is also within normal values, averaging (1.057).
The Tickeron PE Growth Rating for this company is 67 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BBWI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
an operator of retail business
Industry SpecialtyStores
Advertisement